# Regulation of Mucosal Immune Response to Systemic MenB Vaccine

> **NCT00774384** · PHASE2 · COMPLETED · sponsor: **University Hospitals Bristol and Weston NHS Foundation Trust** · enrollment: 9 (actual)

## Conditions studied

- Meningococcal Infections

## Interventions

- **BIOLOGICAL:** NZ MenB OMV vaccine (NZ98/254)

## Key facts

- **NCT ID:** NCT00774384
- **Lead sponsor:** University Hospitals Bristol and Weston NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2016-11-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774384, "Regulation of Mucosal Immune Response to Systemic MenB Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00774384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*